Skip to content
AwardedCzechiaGoodsCZK 71,119,000

Selektivní Imunosupresiva – Ustekinumab V. - Stelara

Published
Published 17 September 2025
Deadline
Closed 21 October 2025

Overview

Předmětem veřejné zakázky jsou dodávky léčivých přípravků s obsahem účinné látky ustekinumab pro léčbu pacientů ve schválených indikacích Crohnovy choroby dle platného SPC a indikačních omezení úhrady v době podání nabídky.

Key details

Country
Czechia
Status
Awarded
Category
Goods
Estimated value
CZK 71,119,000
Procedure
Open
SME suitable
Yes
Published
17 September 2025
Deadline
Closed
Classification (CPV)
Immunosuppressive agents

Award outcome

Awarded value
CZK 44,830,942
Award date
5 November 2025
Contract period
1 December 2025 → 10 November 2029
Winner
  • Janssen-Cilag s.r.o.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    26 November 2025

  2. Contract Notice

    17 September 2025

Contracting authority

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Selektivní Imunosupresiva – Ustekinumab V. - Stelara — won by Janssen-Cilag s.r.o. — Skim